Overview

Changes of Left Ventricular Mass and Cardiac Function in Patients With Active Acromegaly During Treatment With the Growth Hormone Receptor Antagonist Pegvisomant

Status:
Unknown status

Trial end date:
2010-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate changes in left ventricular mass and cardiac function in patients with active acromegaly before and after treatment with the growth hormone receptor antagonist pegvisomant for one year.

Phase:

Phase 4

Details

Lead Sponsor:

University of Wuerzburg

Collaborator:

Pfizer

Treatments:

Hormones